• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Video

Differences in Isotretinoin Formulation

Author(s):

James Q. Del Rosso, DO

An expert in dermatology reviews the differences in Isotretinoin and highlights utilization requirements in patients prescribed this treatment.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!
Related Videos
Video 2 - 1 KOL featured in, "Adolescent Acne Management: Strategic Approaches and Leveraging Clascoterone Cream "
Video 1 - 1 KOL featured in, "Comprehensive Acne Management: Exploring the Role of Combination and Food Independent Treatments in an Adolescent Treatment-Naïve Patient "
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Heather Woolery-Lloyd, MD, FAAD, an expert on acne
Related Content
Isotretinoin Often Continued Despite Mood Concerns
April 22nd 2025

Isotretinoin Often Continued Despite Mood Concerns

The Cutaneous Connection- Episode 12: Antibiotics for Acne
November 23rd 2020

The Cutaneous Connection- Episode 12: Antibiotics for Acne

Microneedles Offer a New Hope for Nodular Acne Treatment
April 10th 2025

Microneedles Offer a New Hope for Nodular Acne Treatment

The Cutaneous Connection- Episode 10: Maskne
November 5th 2020

The Cutaneous Connection- Episode 10: Maskne

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis
March 28th 2025

Fixed-Dose Acne Treatment Gel is Safe and Effective for Hispanic Patients, According to Post-Hoc Analysis

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne
March 27th 2025

Topical Xyngari Meets All Primary Endpoints in Phase 3 Study for Moderate to Severe Acne

© 2025 MJH Life Sciences

All rights reserved.